Related Experiment Video
Updated: Feb 17, 2026

08:57
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
2.7K
Malignant Gastrointestinal Neuroectodermal Tumor: a Unique Rare Neoplasm.
1Sir Gangaram Hospital, Rajinder Nagar, New Delhi, 110060 India.
Indian Journal of Surgical Oncology
|December 6, 2017
Summary
Malignant gastrointestinal neuroectodermal tumor (GNET) is a rare, aggressive cancer. This case report details a GNET in a 55-year-old female, highlighting its challenging diagnosis and poor prognosis.
Area of Science:
- Gastrointestinal pathology
- Oncology
- Surgical pathology
Background:
- Malignant gastrointestinal neuroectodermal tumor (GNET), also known as clear cell sarcoma-like gastrointestinal tumor (CCSLGT), is a rare and aggressive neoplasm.
- GNET exhibits neural differentiation but lacks melanocytic markers, necessitating distinction from mimickers.
- The pathogenesis of GNET remains largely unknown.
Observation:
- This report presents a case of GNET in a 55-year-old female patient.
- The tumor demonstrated aggressive characteristics, including potential for local recurrence and metastasis.
- Diagnostic challenges arise due to its rarity and resemblance to other gastrointestinal malignancies.
Findings:
- The patient's GNET showed evidence of neural differentiation.
- Immunohistochemical and ultrastructural analyses did not reveal melanocytic differentiation.
- The aggressive clinical course underscores the importance of accurate diagnosis.
Implications:
- Accurate and timely diagnosis of GNET is crucial for appropriate patient management and treatment planning.
- Further research into GNET pathogenesis may lead to targeted therapies.
- Understanding GNET's distinct features is vital for differentiating it from other gastrointestinal tumors.
Keywords:
CCSLGTClear cell sarcoma-like gastrointestinal tumorGNETGastrointestinal neuroectodermal tumorJejunum
